56706 Federal Register / Vol. 70, No. 187 / Wednesday, September 28, 2005 / Notices 

Trans # Acquiring Acquired Entities 

20051502 ................ TUI AG ................................................. CP Ships Limited ................................. CP Ships Limited 

20051509 ................ Sybase, Inc .......................................... Extended Systems Incorporated .......... Extended Systems Incorporated 

20051515 ................ Sentry Insurance, a Mutual Company Royal & SunAlliance Insurance Group 

plc.

Viking Insurance Company of Wisconsin 

Transactions Granted Early Termination—09/06/2005 

20051282 ................ Walters Industries, Inc ......................... DLJ Merchant Banking Partners II, L.P Mueller Water Products, Inc. 

20051422 ................ Citigroup, Inc ........................................ Receivable Management Services 

Holding Corp.

Receivable Management Services 

Holding Corp. 

20051505 ................ The Goldman Sachs Group, Inc .......... Allmerica Financial Corporation ........... Allmerica Financial Investment Management Services, Inc., Allmerica Financial Life Insurance & Annuity Co. 

20051507 ................ Paul G. Allen, c/o Vulcan Ventures Incorporated.Sempra Energy .................................... Energy Center Investments 

20051508 ................ Plains All American Pipeline, L.P ........ Sempra Energy .................................... Energy Center Investments Corp. 

Transactions Granted Early Termination—09/07/2005 

20051510 ................ Permira Europe III L.P. 2 ..................... Hirschmann Industrial Holdings Ltd ..... Hirschmann Industrial Holdings Ltd. 

Transactions Granted Early Termination—09/08/2005 

20051020 ................ ScanSoft, Inc ........................................ Nuance Communications, Inc .............. Nuance Communications, Inc. 

20051435 ................ News Corporation ................................ Scout Media, Inc .................................. Scout Media, Inc. 

20051487 ................ American Securities Partners III, L.P ... Weasler Holdings LLC ......................... Weasler Engineering, Inc. 

FOR FURTHER INFORMATION CONTACT: 

Sandra M. Peay, Contact Representative, 

or Renee Hallman, Contact 

Representative, Federal Trade 

Commission, Premerger Notification 

Office, Bureau of Competition, Room H–

303, Washington, DC 20580, (202) 326–

3100. 

By direction of the Commission. 

Donald S. Clark, 

Secretary. 

[FR Doc. 05–19317 Filed 9–27–05; 8:45 am] 

BILLING CODE 6750–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Notice of Meeting: Secretary’s 

Advisory Committee on Genetics, 

Health, and Society 

Pursuant to Public Law 92–463, 

notice is hereby given of the eighth 

meeting of the Secretary’s Advisory 

Committee on Genetics, Health, and 

Society (SACGHS), U.S. Public Health 

Service. The meeting will be held from 

8:30 a.m. to 6 p.m. on October 19, 2005 

and 8:30 a.m. to 5 p.m. on October 20, 

2005 at the Bethesda North Marriott 

Hotel, 5701 Marinelli Road, North 

Bethesda, Maryland. The meeting will 

be open to the public with attendance 

limited to space available. The meeting 

will be webcast. 

The first half of the meeting will be 

devoted to the issue of large population 

studies of genetic variation, the 

environment and common disease. The 

Committee is working to identify salient 

scientific, ethical, and policy issues and 

questions associated with such studies 

and processes that could be employed to 

address them. On October 19, the 

Committee will gather input from 

several leaders in science and bioethics 

about the policy issues and how to 

address them, including mechanisms for 

engaging the general public. October 

20th will be devoted to the further 

exploration of current issues in 

pharmacogenomics. The Committee is 

developing a report to the Secretary on 

this topic, and at this meeting they will 

explore the financial and economic 

considerations involved in integrating 

pharmacogenomics into clinical practice 

as well as delve more deeply into 

certain ethical, legal and social issues 

raised by pharmacogenomics. Time will 

be provided each day for public 

comments, and the public is encouraged 

to provide its perspectives to the 

Committee on these topics or any others 

related to the development and use of 

genetic technologies. 

Under authority of 42 U.S.C. 217a, 

Section 222 of the Public Health Service 

Act, as amended, the Department of 

Health and Human Services established 

SACGHS to serve as a public forum for 

deliberations on the broad range of 

human health and societal issues raised 

by the development and use of genetic 

technologies and, as warranted, to 

provide advice on these issues. The 

draft meeting agenda and other 

information about SACGHS, including 

information about access to the webcast, 

will be available at the following Web 

site: http://www.od.nih.gov/oba/ 

sacghs.htm. 

The Committee would welcome 

hearing from anyone wishing to provide 

public comment on any issue related to 

genetics, health and society. Individuals 

who would like to provide public 

comment or who plan to attend the 

meeting and need special assistance, 

such as sign language interpretation or 

other reasonable accommodations, 

should notify the SACGHS Executive 

Secretary, Ms. Sarah Carr, by telephone 

at (301) 496–9838 or e-mail at 

sc112c@nih.gov. The SACGHS office is 

located at 6705 Rockledge Drive, Suite 

750, Bethesda, MD 20892. 

Dated: September 21, 2005. 

Anthony M. Coelho, Jr., 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 05–19388 Filed 9–27–05; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2005N–0148] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Extralabel Drug 

Use in Animals 

AGENCY: Food and Drug Administration, 

HHS.